Sol Gel Technologies Accquires an Innovative Development from PellePharm

Congratulations to the Israeli dermatology company Sol Gel Technologies, which develops products for the treatment of skin diseases, for acquiring an innovative development from the company PellePharm Inc., which enables the treatment of Gurlin syndrome.

Representing Sol Gel Technologies in the successful transaction – Partners Tami Fishman Jutkowitz and Asaf Hershkovitz alongside Attys. Hen Eran and Shira Shick of the Hi-Tech and Venture Capital Department of our firm.

To Read More